Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: J Med Chem. 2020 Oct 29;63(21):12957–12977. doi: 10.1021/acs.jmedchem.0c01398

Table 5.

In Vitro Properties of Select Compounds

24 25 26 27
Thermodynamic Solubilities (μM)a
pH 7
FESSIF
SGF


37
80
9015


0.2
11
342


5
22
46


38b
19b
9446b
Caco2 AB/BA (cm/sec*10−6)c 1.8/20 5.8/21 7.7/25 5.2/25
Microsomal Stability Clint (mL/min/kg)d
Rat
Dog
Human


14
2
4


22
77
13


8
0
4


15
5
0
Hepatocytes Stability Clint (mL/min/kg)e
Rat
Dog
Human


5
4
0


34
12
3


5
9
2


6
7
3
Protein Binding (% bound)f
Rat
Dog
Human


97
72
97


99
98
99


95
90
96


99
98
98
a

Thermodynamic aqueous solubility (μM) in phosphate buffer (100 mM) at pH 7.0, FeSSIF (Fed State Simulated Intestinal Fluid) at pH 5.0, or SGF (fasted state Simulated Gastrointestinal Fluid) at pH 1.6; shaken for 1 hour then equilibrated overnight at RT.

b

Thermodynamic aqueous solubilities for the crystalline most stable polymorph of 27, identified during later development, in phosphate buffer (50 mM) at pH 6.8, FeSSIF or SGF, shaken for 24 hours at 25 °C (phosphate buffer) or 37 °C (FeSSIF and SGF).

c

Permeability in Caco-2 cells AB (apical to basolateral) and BA (basolateral to apical) movement of 10 μM test compound in 21 day cultured Caco-2 cells ((cm/s) × 10−6).

d

Liver microsomal intrinsic clearance (mL/min/kg protein).

e

Liver hepatocyte intrinsic clearance (mL/min/kg protein).

f

Plasma protein binding determined by equilibrium dialysis.